Find Clinical Trial

Efficacy and safety of the fixed oral perindopril arginine 5 mg/ amlopidine 5 mg combination compared with perindopril tert-butylamine 4 mg alone in patients not adequately controlled with perindopril tert-butylamine 4 mg monotherapy. A randomised double blind 12 weeks study with up titration after


← Back
Study Phase

Phase 3

Therapeutic Area

Cardiovascular Diseases

IndicationHypertension
SponsorInstitut de Recherches Internationales Servier (I.R.I.S)
Active substance/
Medical device

AMLODIPINE, PERINDOPRIL ARGININE,
S005985

Active Substance CodeS005985
Protocol CodeCL3-05985-017


Documents and links

Results summary READ MORE
Scientific publication READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2022 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
Accessibility